Viral Threats Research
Abstract
This effort designs and laboratory tests new vaccine candidates against dengue and other hemorrhagic fever viruses such as hantaviruses (cause of Korean hemorrhagic fever) and other lethal viruses such as Lassa fever (viral disease contracted by ingestion or inhalation of rodents' urine and feces) and Crimean-Congo hemorrhagic fever (severe tick-borne viral disease with a 30% mortality rate in infected humans), and assesses other non-vaccine technologies to protect against such lethal viral diseases. Efforts also include establishing and maintaining of clinical trial sites worldwide.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2015
- Source ID
- 843f2f23c86fb0de2002e9369135c55f
Related Documents
- Root: MEDICAL TECHNOLOGY